We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Takes Aim at Lack of Marketing Authorization
FDA Takes Aim at Lack of Marketing Authorization
February 15, 2011
Warning letters citing companies for lacking marketing authorization for a device, either through clearance of a premarket notification 510(k) or approval of a premarket application (PMA), fall into two categories.